tradingkey.logo

OrganiGram Holdings Inc

OGI
1.920USD
-0.090-4.48%
Close 12/22, 16:00ETQuotes delayed by 15 min
258.17MMarket Cap
LossP/E TTM

OrganiGram Holdings Inc

1.920
-0.090-4.48%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of OrganiGram Holdings Inc

Currency: USD Updated: 2025-12-22

Key Insights

OrganiGram Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 70/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

OrganiGram Holdings Inc's Score

Industry at a Glance

Industry Ranking
70 / 78
Overall Ranking
372 / 4578
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

OrganiGram Holdings Inc Highlights

StrengthsRisks
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 55.42% year-on-year.
Undervalued
The company’s latest PE is -13.78, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.56M shares, decreasing 49.66% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.15.

Financial Health

Currency: USD Updated: 2025-12-22

The current financial score of OrganiGram Holdings Inc is 7.43, ranking 47/78 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 58.21M, representing a year-over-year increase of 88.14%, while its net profit experienced a year-over-year increase of 633.97%.

Score

Industry at a Glance

Previous score
7.30
Change
0.13

Financials

6.76

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

4.33

Operational Efficiency

10.00

Growth Potential

8.64

Shareholder Returns

7.43

OrganiGram Holdings Inc's Company Valuation

Currency: USD Updated: 2025-12-22

The current valuation score of OrganiGram Holdings Inc is 6.05, ranking 64/78 in the Healthcare Providers & Services industry. Its current P/E ratio is -13.78, which is -1682.96% below the recent high of 218.17 and -363.67% above the recent low of -63.90.

Score

Industry at a Glance

Previous score
6.05
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 70/78
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-22

No earnings forecast score is currently available for OrganiGram Holdings Inc. The Healthcare Providers & Services industry's average is 7.54.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-22

The current price momentum score of OrganiGram Holdings Inc is 8.73, ranking 22/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 2.28 and the support level at 1.52, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.99
Change
-0.26

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.074
Buy
RSI(14)
58.595
Neutral
STOCH(KDJ)(9,3,3)
65.914
Sell
ATR(14)
0.160
High Vlolatility
CCI(14)
68.905
Neutral
Williams %R
42.667
Buy
TRIX(12,20)
0.906
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
2.006
Sell
MA10
1.869
Buy
MA20
1.743
Buy
MA50
1.686
Buy
MA100
1.684
Buy
MA200
1.462
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-22

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
British American Tobacco plc
40.13M
+23.22%
Tidal Investments LLC
2.65M
+4.93%
Morgan Stanley & Co. LLC
152.46K
+124.02%
Global X Investments Canada Inc.
839.95K
-1.14%
AdvisorShares Investments, LLC
802.39K
-5.15%
Renaissance Technologies LLC
Star Investors
1.02M
+1.13%
BMO Nesbitt Burns Inc.
309.46K
--
Baader Bank AG
250.64K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-12-22

The current risk assessment score of OrganiGram Holdings Inc is 3.28, ranking 61/78 in the Healthcare Providers & Services industry. The company's beta value is 2.24. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.28
Change
0
Beta vs S&P 500 index
2.24
VaR
+6.32%
240-Day Maximum Drawdown
+49.13%
240-Day Volatility
+66.50%

Return

Best Daily Return
60 days
+17.07%
120 days
+17.07%
5 years
+25.69%
Worst Daily Return
60 days
-6.25%
120 days
-8.33%
5 years
-19.59%
Sharpe Ratio
60 days
+0.86
120 days
+1.52
5 years
-0.31

Risk Assessment

Maximum Drawdown
240 days
+49.13%
3 years
+74.91%
5 years
+95.00%
Return-to-Drawdown Ratio
240 days
+0.28
3 years
-0.20
5 years
-0.19
Skewness
240 days
+0.64
3 years
+0.77
5 years
+0.58

Volatility

Realised Volatility
240 days
+66.50%
5 years
+71.71%
Standardised True Range
240 days
+4.29%
5 years
+13.14%
Downside Risk-Adjusted Return
120 days
+360.33%
240 days
+360.33%
Maximum Daily Upside Volatility
60 days
+62.05%
Maximum Daily Downside Volatility
60 days
+50.52%

Liquidity

Average Turnover Rate
60 days
+0.56%
120 days
+0.48%
5 years
--
Turnover Deviation
20 days
-15.19%
60 days
-39.72%
120 days
-47.83%

Peer Comparison

Healthcare Providers & Services
OrganiGram Holdings Inc
OrganiGram Holdings Inc
OGI
5.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
Alignment Healthcare Inc
ALHC
8.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chemed Corp
Chemed Corp
CHE
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
Lifestance Health Group Inc
LFST
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of OrganiGram Holdings Inc?

The TradingKey Stock Score provides a comprehensive assessment of OrganiGram Holdings Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of OrganiGram Holdings Inc’s performance and outlook.

How do we generate the financial health score of OrganiGram Holdings Inc?

To generate the financial health score of OrganiGram Holdings Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects OrganiGram Holdings Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of OrganiGram Holdings Inc.

How do we generate the company valuation score of OrganiGram Holdings Inc?

To generate the company valuation score of OrganiGram Holdings Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare OrganiGram Holdings Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of OrganiGram Holdings Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of OrganiGram Holdings Inc.

How do we generate the earnings forecast score of OrganiGram Holdings Inc?

To calculate the earnings forecast score of OrganiGram Holdings Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on OrganiGram Holdings Inc’s future.

How do we generate the price momentum score of OrganiGram Holdings Inc?

When generating the price momentum score for OrganiGram Holdings Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of OrganiGram Holdings Inc’s prices. A higher score indicates a more stable short-term price trend for OrganiGram Holdings Inc.

How do we generate the institutional confidence score of OrganiGram Holdings Inc?

To generate the institutional confidence score of OrganiGram Holdings Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about OrganiGram Holdings Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of OrganiGram Holdings Inc.

How do we generate the risk management score of OrganiGram Holdings Inc?

To assess the risk management score of OrganiGram Holdings Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of OrganiGram Holdings Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of OrganiGram Holdings Inc.
KeyAI